Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

RMAT Designation Requests May Rise Or Fall On Manufacturing Changes, Clinical Data Breadth

Executive Summary

Product characterization questions and partial or inconsistent clinical data are among the more common reasons why the US FDA denies, or seeks additional information about, a request for regenerative medicine advanced therapy designation, FDA’s Bryan says; sponsors should consider why they are seeking designation when deciding whether to apply for RMAT, breakthrough therapy or both.


Advertisement

Related Content

Regenerative Medicine Therapies: Manufacturing Changes May Not Impact RMAT Designation
Regenerative Medicine Therapies: Manufacturing Changes May Not Impact RMAT Designation
US FDA Recommends Use Of Pre-Built Facilities To Ease Scale-Up Process For Cell And Gene Therapies
Early-Stage Cell And Gene Therapy Progress: Updates From Casebia, BlueRock, Athersys, Cynata
Want An RMAT Designation? Please Include At Least Some Data, US FDA Tells Sponsors
US FDA’s Breakthrough And RMAT Designations: A Quick Guide
US FDA's Biologics Center Director Expects It Soon Will See 'Growth Spurt'
Regenerative Medicine Clinical Trials: US FDA Supports Studies Comparing Multiple Agents

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS123307

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel